BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19194365)

  • 1. Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
    Rolston KV
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):815-7. PubMed ID: 19194365
    [No Abstract]   [Full Text] [Related]  

  • 2. Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
    Sakoulas G
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):813-5. PubMed ID: 19194364
    [No Abstract]   [Full Text] [Related]  

  • 3. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
    Golden M; Shaib W; Havill N
    Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
    [No Abstract]   [Full Text] [Related]  

  • 5. [The second life of daptomycin: analysis of a successful come-back].
    Decousser JW; Doucet Populaire F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of resistant Gram-positive bacterial infections].
    Lenoble M
    Med Mal Infect; 2011 Sep; 41(9 Suppl):1-6. PubMed ID: 22133738
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
    Gould IM
    J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv17-iv21. PubMed ID: 21521703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract]   [Full Text] [Related]  

  • 10. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
    Mergenhagen KA; Pasko MT
    Ann Pharmacother; 2007 Sep; 41(9):1531-5. PubMed ID: 17652126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 13. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Sheridan KR; Potoski BA; Shields RK; Nau GJ
    Pharmacotherapy; 2010 Dec; 30(12):1247-51. PubMed ID: 21114392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
    Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin].
    Araujo F; Conde Estevez D; Encinas Barrios C
    Farm Hosp; 2012; 36(5):449-51. PubMed ID: 22484104
    [No Abstract]   [Full Text] [Related]  

  • 18. Empirical therapy for serious Gram-positive infections: making the right choice.
    Segreti J
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():5-10. PubMed ID: 19917021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for methicillin-resistant Staphylococcus aureus.
    Torres-Tortosa M; Caballero-Granado FJ; Canueto J
    N Engl J Med; 2006 Nov; 355(20):2153-4; author reply 2155. PubMed ID: 17120350
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy for methicillin-resistant Staphylococcus aureus.
    Siegman-Igra Y; Talan DA
    N Engl J Med; 2006 Nov; 355(20):2153; author reply 2155. PubMed ID: 17108348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.